Boston Scientific is spending $14.5 billion in cash and stock to buy Penumbra, another medical-device maker that makes ...

The key opportunities in the Blood Clot Retrieval Devices Market involve advancing device technology and improving supply ...

Long COVID affects an estimated 65 million people worldwide and can damage the brain, heart, blood vessels, and immune system ...

With the planned purchase, Boston Scientific will gain a portfolio of devices to remove clots from blood vessels.

Venous insufficiency is a condition where the pressure inside the veins is high enough that fluid comes out of the blood ...

Your recent column regarding edema from venous insufficiency caught my interest since I was diagnosed with venous ...

Fluid can also come out of structurally normal veins when the oncotic pressure (the tendency for fluid to stay in the veins ...

Strategic investment follows a transformative year marked by the national launch of the AVENTUS thrombectomy system.

New Orleans Saints wide receiver Chris Olave will miss the team’s season finale against the Arizona Cardinals after being diagnosed with a blood clot in his lung. According to ESPN, Olave, who missed ...

Community Medical Centers was forced to pay nearly $200,000 for penalties related to patient harm and death, Merced Sun-Star ...

Four-year-old Ellie Rudd – who loved mud and getting dressed up and having dance parties with her brother and sisters – died ...

Boston Scientific is capping off a busy week with a major buyout, entering a deal worth about $14.5 billion to acquire ...